SION (Sionna Pharma) Total Business Assets

SION (Sionna Therapeutics, Inc.) - company brandmark

Sionna Therapeutics Inc (SION) is led by top scientists in the field of hereditary pathology therapies who maintain successful interactions with regulatory bodies. The technological stack is complemented by automated systems for high-precision compound analysis, which accelerate the drug discovery process. The company is developing treatments for cystic fibrosis, aiming for leadership in this segment. As illustrated on the chart, the market value of the asset is 317.61.

SION - Sionna Therapeutics Inc Company Total Assets over the range 02/08/2025 - 11/01/2026

Financial and market metric breakdowns for Sionna Pharma (SION)

- stock quotes and analyst forecast:
Share Price sionnatx.com|SION - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Sionna Corp|SION - Total Company Value
- book capitalization information:
Equity per Share Sionna Therapeutics|SION - Book Capitalization|Market Capitalization to Book Value Ratio sionnatx.com|SION - Aggregate Company Assets
- debt and liquidity details:
Total Debt to Capital Coefficient Sionna Therapeutics Inc|SION - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Sionna Corp|SION - Company Debts|Debts to Book Value Sionna Corp|SION - Company Long-Term Debt|Company Short-Term Indebtedness Sionna Therapeutics|Immediate Liquidity Ratio sionnatx.com
- earnings and market ratios statistics:
SION - Net Profit
Basic company analysis:SION sionnatx.com
Mass-produced product of Sionna Therapeutics Inc

The financial stability assessment of Sionna Therapeutics Inc (SION) is based on the aggregate resources controlled by the issuer to implement research and development programs. This market value, calculated inversely via ROA, reflects the future potential of assets, where fluctuations in total equity and liabilities confirm the company's ability to retain a unique staff of geneticists and cystic fibrosis researchers through a robust material, technical, and intellectual base.

Main competitors

Total Business Assets TEM|QGEN (Qiagen) - Company Total Assets|Total Business Assets IONS (Ionis Pharmaceuticals, Inc.)|Aggregate Company Assets Repligen Corp. (RGEN)|Avidity Corp - Total Business Assets|Company Total Assets CRSP (CRISPR Therapeutics AG)|Company Total Assets genedx.com WGS|RARE - Aggregate Company Assets|Company Total Asset Base Beam Therapeutics Inc BEAM|SRPT: Company Total Assets|TWST - Company Total Asset Base|Aggregate Company Assets 10x Genomics, Inc.|Company Assets intelliatx.com NTLA|Aggregate Company Assets Stoke Therapeutics, Inc. (STOK)|BioLife Solutions Inc - Total Business Assets|Aggregate Company Assets Wave Life Sciences Corp WVE|MAZE: Total Business Assets|Prime Medicine, Inc. - Company Total Assets|TSHA - Company Total Assets|QURE (uniQure) - Cumulative Company Assets|MeiraGTx Holdings - Aggregate Asset Value|Cumulative Company Assets RGNX|SLDB (Solid Corp) - Aggregate Business Assets|Company Total Assets OCGN|PACB (pacb.com) - Aggregate Asset Value|Company Total Assets BNTC (Benitec Biopharma)|Design Therapeutics Inc (DSGN) - Company Assets|RCKT - Aggregate Company Assets|Aggregate Asset Value FDMT (4D Molecular Corp)|LXEO: Company Total Assets|Korro Bio (KRRO) - Company Total Assets|Aggregate Company Assets Editas Medicine|Silence Therapeutics PLC - Total Asset Value of Company|Company Total Assets PRQR|CDXS - Company Assets|Sangamo Therapeutics - Cumulative Company Assets|Company Total Assets Nautilus Biotechnology, Inc. NAUT|MGX: Cumulative Company Assets|precisionbiosciences.com - Aggregate Business Assets|GBIO: Company Total Assets|BOLD - Company Total Asset Base|XCUR (Exicure Inc.) - Company Total Assets|Cumulative Company Assets Celsion Corporation (IMNN)|Aggregate Company Assets Phio Pharmaceuticals (PHIO)|Company Total Asset Base mustangbio.com|TransCode Therapeutics, Inc. - Cumulative Company Assets|Aggregate Asset Value BNGO|Applied DNA Sciences - Company Total Assets|Company Total Asset Base bluebirdbio.com BLUE|immunoprecise.com (IPA) - Aggregate Company Assets|Total Business Assets OMGA|OMIC (Singular Genomics Systems Inc) - Company Total Assets|Cumulative Company Assets Regulus (RGLS)|Aggregate Company Assets Syros Pharmaceuticals (SYRS)|Company Total Asset Base telesisbio.com|Company Total Assets TCON (TRACON Pharmaceuticals, Inc.)|Company Total Asset Base Unity Biotechnology Inc. (UBX)